These epigenetic changes suppress the transcription of nearby tumour-suppressor genes CDKN2A and CDKN2B, thereby linking upstream signals to downstream cell cycle and stress response pathways relevant to both glaucoma and CVD [20,21]. Here, CDKN2B is linked to glaucoma.